Clinical Trial Update: Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 long-term safety update for ARQ-151 cream in adults with chronic plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ARQ-151 cream (ARQ-151)

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-18